Stocks To Watch: Swiggy, Reliance Ind, Aurobindo Pharma, Lupin, Bharat Forge, Afcons Infra, RITES, Lemon Tree Hotels

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a subdued opening on Monday. Here’s a look at the key stocks to watch in trade.

Stocks in Focus: GIFT Nifty was trading 11.50 points or 0.04% higher at 24,787 indicating a muted start for domestic indices NSE Nifty 50 and BSE Sensex on Monday. Previously, on Friday, the NSE Nifty 50 closed the session 220 points or 0.89% higher at 24,768, while the BSE Sensex rose 843 points or 1.04% to close at 82,133.

Stocks to watch on December 16, 2024

Swiggy 

Swiggy launched a new service called “Scenes” under its out-of-home vertical, Dineout. This feature enables users to book parties, events, and live music at Swiggy’s partner restaurants. “Scenes” is currently live in Delhi-NCR, Bengaluru, and Mumbai. In Delhi-NCR, users can access approximately 55 events, including New Year celebrations, Christmas parties, and live music shows.

Reliance Industries 

Reliance Industries has bought a 74% stake in an industrial area developer, situated in the country’s financial hub of Mumbai, for Rs 1,628 crore rupees ($192 million).

Aurobindo Pharma 

Aurobindo Pharma received an order from the Additional Commissioner (ST), Appellate authority, Vijayawada, Andhra Pradesh, passed under relevant provisions of the CGST Act, 2017 and APGST Act, 2017 for the financial years 2017-18 (from July 2017) to 2019-20 demanding reversal of ITC and payment of GST amounting to Rs 5.68 crore along with an interest of Rs 4.80 crore.

Lupin

Lupin announced the acquisition of trademarks for three anti-diabetes brands — Gibtulio, Gibtulio Met, and Ajaduo — from Boehringer Ingelheim International GmbH. The acquisition is anticipated to enhance Lupin’s diabetes offerings in India., a critical therapeutic segment for the company.

Bharat Forge 

Bharat Forge said its wholly-owned subsidiary Kalyani Strategic Systems has announced a €2.50-million investment to acquire a 25% equity stake in Italy-based Edgelab SpA.

Afcons Infrastructure 

Afcons Infrastructure, a subsidiary of Shapoorji Pallonji Group, received an LOA from Madhya Pradesh Metro Rail Co., legally confirming the selection and award of the Bhopal Metro Phase 1 project. The 12.915 km stretch of Bhopal Metro’s blue line will cost about Rs 1006.74 crore. It is expected to be completed in 36 months via EPC mode.

RITES 

RITES has been awarded a contract worth Rs 297.67 crore by the Ministry of External Affairs (MEA).

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s